Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

9.3K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

17.0K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
17.0K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

4.2K
A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K
Non-nuclear Inheritance01:29

Non-nuclear Inheritance

23.3K
Most DNA resides in the nucleus of a cell. However, some organelles in the cell cytoplasm⁠—such as chloroplasts and mitochondria⁠—also have their own DNA. These organelles replicate their DNA independently of the nuclear DNA of the cell in which they reside. Non-nuclear inheritance describes the inheritance of genes from structures other than the nucleus.
23.3K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.4K
Overview
80.4K
Genomics02:02

Genomics

40.9K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absorption, metabolism, and excretion of single dose oral [<sup>14</sup>C]camizestrant in healthy human female participants.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Identification, synthesis, and characterization of a unique N-glucuronide of an acid metabolite of camizestrant (AZD9833) in humans.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

In vitro gametogenesis, 'social infertility', and the legacy of the Warnock report.

Human fertility (Cambridge, England)·2025
Same author

Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidates.

Toxicology research·2025
Same author

Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations.

Journal of medicinal chemistry·2024
Same author

Ecosystem engineers enhance the multifunctionality of an urban novel ecosystem: Population persistence and ecosystem resilience since the 1980s.

The Science of the total environment·2024

Related Experiment Video

Updated: Feb 11, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K

Germline Genetic Modification and Identity: the Mitochondrial and Nuclear Genomes.

Rosamund Scott, Stephen Wilkinson

    Oxford Journal of Legal Studies
    |April 20, 2018
    PubMed
    Summary

    The UK

    Area of Science:

    • Bioethics
    • Genetics Law
    • Reproductive Technologies

    Background:

    • UK legal reform permits mitochondrial replacement techniques (MRTs).
    • Government distinguishes MRTs from germline genetic modification (nuclear genome editing).
    • Ethical debates surrounding human embryo modification and reproductive technologies.

    Purpose of the Study:

    • Analyze legal and policy discourse on 'germline genetic modification' in UK/US.
    • Evaluate ethical concerns regarding personal identity and genetic modification.
    • Compare MRTs and nuclear genome editing (e.g., CRISPR/Cas-9) concerning identity.

    Main Methods:

    • Legal and policy analysis of UK/US debates.
    • Ethical evaluation of identity concerns in genetic modification.
    Keywords:
    CRISPR/Cas-9genetic modificationgenome editinggermlineidentitymitochondrial replacement

    More Related Videos

    Author Spotlight: Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification
    11:44

    Author Spotlight: Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification

    Published on: March 24, 2023

    5.1K
    A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes
    09:10

    A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes

    Published on: May 22, 2018

    10.1K

    Related Experiment Videos

    Last Updated: Feb 11, 2026

    Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
    07:24

    Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

    Published on: February 10, 2023

    2.0K
    Author Spotlight: Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification
    11:44

    Author Spotlight: Targeted Microinjection and Electroporation of Primate Cerebral Organoids for Genetic Modification

    Published on: March 24, 2023

    5.1K
    A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes
    09:10

    A Fast and Quantitative Method for Post-translational Modification and Variant Enabled Mapping of Peptides to Genomes

    Published on: May 22, 2018

    10.1K
  • Comparative assessment of MRTs and nuclear genome editing.

    • Main Results:

    • The term 'germline genetic modification' is used variably in legal/policy contexts.
    • MRTs and nuclear genome editing share significant ethical considerations regarding identity.
    • The distinction between MRTs and nuclear genetic modification based on identity is less clear than assumed.

    Conclusions:

    • The perceived difference between MRTs and nuclear genetic modification regarding identity is overstated.
    • Current legal and policy justifications for differentiating MRTs may be undermined.
    • Identity considerations alone are insufficient to support distinct legal/policy treatment of MRTs versus nuclear genetic modification.